Physician profile
Jaime Benrey
NPI 1003810854
$11,179.38
in general payments reported to CMS, 2019-2025
29 companies · $666 in 2025
The $666 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,958 · 2020: $2,348 · 2021: $1,629 · 2022: $1,249 · 2023: $1,515 · 2024: $813 · 2025: $666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,995.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,301.59 | 2019-2025 | Aveir, Gallant, Quadra Assura |
| Medtronic Vascular, INC. | $3,313.20 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $389.47 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $356.87 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $326.03 | 2021-2024 | Xarelto |
| Abiomed | $238.54 | 2022-2023 | Impella |
| Irhythm Technologies, INC. | $181.41 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $109.00 | 2023-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.88 | 2022-2025 | Jardiance |
| Medtronic, INC. | $77.46 | 2022-2025 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Edwards Lifesciences Corporation | $76.88 | 2020-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Actelion Pharmaceuticals US, INC. | $75.86 | 2024-2025 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals LP | $70.87 | 2020-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $68.69 | 2022-2024 | Camzyos |
| Lexicon Pharmaceuticals, INC. | $56.17 | 2023 | Inpefa |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $55.96 | 2022 | |
| Boston Scientific Corporation | $54.75 | 2020-2025 | Bodyguardian |
| Amgen INC. | $48.33 | 2019-2024 | Repatha |
| Pfizer INC. | $45.32 | 2019-2024 | |
| Inspire Medical Systems, INC. | $37.65 | 2025 | Inspire |
| Cordis US Corp. | $36.49 | 2024 | Mynx Venous Vcd |
| Scpharmaceuticals INC. | $29.96 | 2023-2024 | |
| Abbvie INC. | $29.88 | 2022 | |
| Cvrx, INC. | $25.27 | 2023 | Barostim Neo System |
| Regeneron Healthcare Solutions, INC. | $20.16 | 2024 | Dupixent |
| Novo Nordisk INC | $19.18 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $18.84 | 2024 | Arcalyst |
| Intra-Sana Laboratories | $17.73 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Bayer Healthcare Pharmaceuticals INC. | $14.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Benrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.